Search
for

    Research 10 of 1000+

    1. Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab) Journal of Clinical Oncology · 2008 · 3 citations
    2. Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events. PubMed · 2006 · 91 citations
    3. Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor PLoS ONE · 2012 · 32 citations
    4. Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment Journal of Cancer Research and Therapeutics · 2019 · 3 citations
    5. Severe scarring alopecia associated with combinational use of ficlatuzumab and gefitinib: a clinical and immunohistochemistry study Journal of dermatological science · 2012 · 1 citations
    6. The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma Current Dermatology Reports · 2013 · 6 citations
    7. Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice Cancer Research · 2009 · 53 citations
    8. Management of Toxicities of Targeted Therapies Elsevier eBooks · 2018 · 2 citations
    9. Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer Journal of thoracic oncology · 2010 · 12 citations
    10. Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review Frontiers in Oncology · 2024 · 3 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →